Stretch Mark Clinical Trial
Official title:
Assessment of Efficacy, Safety and Tolerability of Stratamark® (Innovative Self-drying Silicone Gel) in the Treatment and Prevention of Striae Distensae
Stretch marks (striae distensae) are a form of scarring that is a natural result of
pregnancy, obesity and in some instances occur due to puberty or steroid use. For some
people, the stretch marks do not cause a problem, but in many circumstances they can cause
physical symptoms such as itchiness, tenderness and pain. For many people stretch marks are
also embarrassing and can have detrimental effects on a patient's mood and self-esteem.
Stretch marks that result from pregnancy most commonly occur on the abdomen, breasts and
thighs.
Topical silicone gel was developed nearly thirty years ago to be used in the treatment of
widespread hypertrophic scars (abnormal scars, which may be red or raised/depressed itchy or
painful). Since this time it has been used successfully on most scar types. . Since stretch
marks are a form of scarring it is thought that topical silicone gel may be helpful for this
scar type also. Stratamark™ has been developed using different forms of silicone polymers, in
a gel format, that dries to form a very thin and flexible silicone gel sheet making it a
convenient therapy for the treatment and prevention of stretch marks.
The aim of this clinical research study is to prove or disprove the efficacy, safety and
tolerability of Stratamark™ in the prevention and treatment of stretch marks. In addition,
the knowledge gained from this study may be of benefit to many future patients
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05097573 -
Clinical Evaluation of the Efficacy of Fractional Radiofrequency for the Treatment and Reduction of Stretch Marks
|
N/A | |
Recruiting |
NCT05987319 -
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
|
N/A | |
Recruiting |
NCT06117293 -
Safety and Efficacy Evaluation of the Mosaic Ultra Device
|
N/A |